HCW Biologics (HCWB) Shares Outstanding (2020 - 2026)

HCW Biologics (HCWB) has reported Shares Outstanding (Entity) for 7 consecutive years, with $1.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 347.6% year-over-year to $1.3 million; the trailing twelve-month figure through Jun 2026 stood at $1.3 million (up 347.6% YoY), and the FY2025 full-year result was $349617.0, up 86.74% from the prior year.
• Shares Outstanding (Entity) improved to $1.3 million in Q2 2026 per HCWB's latest filing, from $349617.0 in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $7.5 million in Q1 2025 and bottomed at $149152.0 in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $692808.4 across 5 years, with a median of $157597.0 in 2023.
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) advanced 0.26% in 2023, then jumped 4652.01% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $149528.0 in 2022, then gained by 5.4% to $157597.0 in 2023, then rose by 18.8% to $187226.0 in 2024, then jumped by 86.74% to $349617.0 in 2025, then soared by 279.83% to $1.3 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $1.3 million, $349617.0, and $450268.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.